Tertomotide (GV1001) Hydrochloride
Telomerase-derived 16-mer research peptide.
Oncology Research Peptides
CIGB-300 (P15-Tat) is a synthetic cyclic cell-penetrating peptide studied as an anti-CK2 (casein kinase 2) research compound and reference anticancer peptide. It is investigated in oncology cell-biology research for dose-dependent antiproliferative and pro-apoptotic effects across tumor cell-line panels, angiogenesis-pathway modulation, and in-vivo tumor-model research. Supplied as a research-grade reagent only.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Telomerase-derived 16-mer research peptide.
PSP-94-derived antitumor research peptide.
Tumor-penetrating cyclic peptide; delivery-enhancement research reagent.